XNNV:XETRA:XETRA-Xtrackers MSCI Innovation UCITS ETF 1C USD Acc (EUR)

ETF | Others |

Last Closing

USD 39.655

Change

-0.05 (-0.13)%

Market Cap

N/A

Volume

2.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.87 (-4.25%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-4.83 (-4.92%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-1.19 (-5.21%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.49 (-3.83%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.28 (-5.29%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.93 (-4.19%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.70 (-5.54%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-1.37 (-2.45%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.34 (-3.39%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.03 (-0.02%)

USD 12.26B

ETFs Containing XNNV:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.76% 14% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.76% 16% F 18% F
Trailing 12 Months  
Capital Gain 8.50% 77% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.50% 77% C+ 73% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 13.19% 76% C+ 75% C
Dividend Return 13.19% 76% C+ 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.89% 48% F 58% F
Risk Adjusted Return 102.37% 86% B+ 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.